Strategic Planning

FACT’s strategic plan anticipates and addresses opportunities and challenges for the next several years. The strategic plan also identifies several “Defining Objectives.” Although all the goals in a strategic plan are important and meant to be accomplished, several are designated as highest priority. Accomplishing these priority goals defines FACT’s success over the next period of time. View the FACT Strategic Plan 2017-2020.

The three defining objectives and additional goals for the 2017-2020 period are:

  • Defining Objective #1: INSPECTIONS
    The highest possible level of excellence and consistency in inspections of programs and facilities.
  • Defining Objective #2: IMMUNE EFFECTOR CELL THERAPY
    Rapid mobilization of an accreditation service for immune effector cellular therapy programs.
  • Defining Objective #3: FINANCES
    Sufficient financial resources to sustain operations and build reserves for the development of mission-directed products and services and for surviving an economic downturn.
  • Strategic Objective #4: REGENERATIVE MEDICINE
    Continued promotion of the FACT Common Standards for Cellular Therapies, and readiness to introduce disease- or medical specialty-specific standards when appropriate.
  • Strategic Objective #5: CLINICAL OUTCOMES IMPROVEMENT
    Cellular therapy programs that know how to prevent, investigate and correct deficiencies in clinical outcomes.
  • Strategic Objective #6: STANDARDS
    Clear and user-friendly FACT standards and effective transition between editions of standards.
  • Strategic Objective #7: ACCREDITATION
    Consistency in the awarding of FACT accreditation.
  • Strategic Objective #8: CORD BLOOD BANKING
    Recognition of FACT as the premier accreditation for both public and private cord blood banks.
  • Strategic Objective #9: EDUCATION
    Recognition that education is as important as standards and accreditation within FACT’s mission to promote quality in cellular therapy.
  • Strategic Objective #10: ORGANIZATIONAL EFFECTIVENESS
    Organizational health is one of FACT’s greatest strengths.

 

Ask FACT

FAQ

Ask a Peer

As a Matter of FACT

FACT was formally known as “FAHCT” (The Foundation for the Accreditation of Hematopoietic Cellular Therapy) until it expanded operations into other cellular therapies beyond hematopoietic cells.

Accreditation Success Story

The University of Utah Blood and Marrow Transplant Program began at the University Hospital in Salt Lake City in 1990. The program has been FACT accredited for 10 years, and offers suggestions for large programs considering FACT accreditation. Read more